Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma. - Dieter, S. M.; Heining, C.; Agaimy, A.; Huebschmann, D.; Bonekamp, D.; Hutter, B.; Ehrenberg, K. R.; Fröhlich, M.; Schlesner, M.; Scholl, C.; Schlemmer, H.-P.; Wolf, S.; et al. (Annals of Oncology, 2017)